Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors Arjun MittraGeraldine H. O’ Sullivan CoyneAlice P. Chen Original Article Open access 27 November 2023 Pages: 177 - 189
Enhanced anticancer synergy of LOM612 in combination with selinexor: FOXO1 nuclear translocation-mediated inhibition of Wnt/β-catenin signaling pathway in breast cancer Shengxi XuYingfang ShiSen Li Original Article 05 December 2023 Pages: 191 - 202
Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3β pathway Liru HuangFuhong LiuPing Hu Original Article 23 December 2023 Pages: 203 - 213
Effect of vitamin E on doxorubicin and paclitaxel-induced memory impairments in male rats Ahmad A. AltarifiKareem SawaliOmar Khabour Original Article 06 November 2023 Pages: 215 - 224
A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC? Angeline GinzacEmilie ThivatXavier Durando Original Article Open access 07 November 2023 Pages: 225 - 236
Prognostic value of RRM1 and its effect on chemoresistance in pancreatic cancer Xingyi LinYing TanYinting Chen Original Article 01 December 2023 Pages: 237 - 251
Bioequivalence, food effect and comparative pharmacokinetics of SUVN-1105, a novel granule formulation of abiraterone acetate, to Zytiga in healthy male subjects Ramakrishna NirogiJyothsna RavulaVeera Raghava Chowdary Palacharla Original Article 29 December 2023 Pages: 253 - 264
Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma Hajime YasudaNaoko KagaMiki Ando Short Communication 26 September 2023 Pages: 265 - 268
Retraction Note: Induction of apoptosis by [6]-gingerol associated with the modulation of p53 and involvement of mitochondrial signaling pathway in B[a]P-induced mouse skin tumorigenesis Nidhi NigamJasmine GeorgeYogeshwer Shukla Retraction Note 13 November 2023 Pages: 269 - 269
Retraction Note: Atrial natriuretic peptide protects against cisplatin‑induced granulocytopenia Takashi NojiriHiroshi HosodaKenji Kangawa Retraction Note 21 December 2023 Pages: 271 - 271